Twist Bioscience Corp Stock Beneish M Score
| TWST Stock | USD 31.50 2.05 6.96% |
Twist | Beneish M Score |
At this time, it appears that Twist Bioscience Corp is an unlikely manipulator. The earnings manipulation may begin if Twist Bioscience's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Twist Bioscience executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Twist Bioscience's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-5.56
Beneish M Score - Unlikely Manipulator
Twist Bioscience Beneish M-Score Indicator Trends
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Twist Bioscience's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Net Receivables | 53.2 M | 50.7 M |
|
| |||||
| Total Revenue | 296 M | 281.9 M |
|
| |||||
| Total Assets | 454.3 M | 892.9 M |
|
| |||||
| Total Current Assets | 314.2 M | 487.9 M |
|
| |||||
| Non Current Assets Total | 425.2 M | 405 M |
|
| |||||
| Property Plant Equipment | 258.9 M | 246.5 M |
|
| |||||
| Selling General Administrative | 110.3 M | 218.2 M |
|
| |||||
| Total Current Liabilities | 45.4 M | 84.3 M |
|
| |||||
| Non Current Liabilities Total | 90.3 M | 71.7 M |
|
| |||||
| Short Term Debt | 8.9 M | 17.1 M |
|
| |||||
| Long Term Debt | 1.2 M | 1.3 M |
|
|
Twist Bioscience Corp Beneish M-Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Twist Bioscience's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Twist Bioscience in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Twist Bioscience's degree of accounting gimmicks and manipulations.
Click cells to compare fundamentals
About Twist Bioscience Beneish M Score
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Depreciation And Amortization |
|
Twist Bioscience Earnings Manipulation Drivers
Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Twist Bioscience. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Receivables | 26.4M | 28.5M | 40.3M | 44.1M | 50.7M | 53.2M | |
| Total Revenue | 90.1M | 132.3M | 203.6M | 245.1M | 281.9M | 296.0M | |
| Total Assets | 398.9M | 702.1M | 961.4M | 776.4M | 892.9M | 454.3M | |
| Total Current Assets | 334.9M | 546.5M | 596.5M | 424.3M | 487.9M | 314.2M | |
| Net Debt | (57.7M) | (402.9M) | (283.8M) | (192.4M) | (173.2M) | (181.8M) | |
| Short Term Debt | 9.7M | 9.8M | 13.6M | 14.9M | 17.1M | 8.9M | |
| Operating Income | (117.6M) | (153.3M) | (249.0M) | (217.2M) | (195.4M) | (205.2M) | |
| Investments | (104.8M) | 183.7M | (117.2M) | 50.6M | 58.2M | 61.1M | |
| Gross Profit Margin | 0.32 | 0.39 | 0.41 | 0.37 | 0.33 | 0.35 |
About Twist Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Twist Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Twist Bioscience Investors Sentiment
The influence of Twist Bioscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Twist. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with an investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Twist Bioscience.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.
Currently Active Assets on Macroaxis
When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:Check out Twist Bioscience Piotroski F Score and Twist Bioscience Altman Z Score analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.61) | Revenue Per Share 4.591 | Quarterly Revenue Growth 0.318 | Return On Assets (0.16) | Return On Equity (0.31) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.